CURRICULUM VITAE July 5, 2014 Name Chang-Kwon Oh Date of Birth August 15, 1961 Present Academic & Hospital Appointment Professor, Department of Surgery Ajou University, School of Medicine Chief, Department of Transplantation & Vascular Surgery Ajou University Hospital Office Address Department of Surgery Ajou University, School of Medicine 5 Wonchon-Dong, Yeongtong-Gu Suwon, 442-749, KOREA Telephone 82-31-219-5199 (work) 82-31-217-7281 (home) Fax 82-31-219-5755 E-mail ohck@ajou.ac.kr
Education 1979-1981 Premedical School of Yonsei University, Seoul, Korea 1981-1985 M.D. degree, Yonsei University College of Medicine, Seoul, Korea 1993-1995 Master degree, Yonsei University Graduate School, Seoul, Korea 1995-1998 Ph.D. degree, Yonsei University Graduate School, Seoul, Korea Carrier 1985-1986 Internship, Severance Hospital Yonsei University College of Medicine, Seoul, Korea 1986-1990 Residency of Surgery, Severance Hospital Yonsei University College of Medicine, Seoul, Korea 1990 Korean Board of Surgery 1990-1993 Served in Korean Army as an army surgeon 1993-1995 Clinical Fellowship, Transplantation & Immunology, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea 1995 Certified USMLE (United States Medical Licensing Examination) 1995-1998 Instructor, Department of Surgery 1998-2003 Assistant Professor, Department of Surgery 1998-2000 Clinical Fellowship (Transplantation), Department of Surgery University of Virginia, Health Sciences Center, USA 2000 Certified ASTS (American Society of Transplant Surgeons) 2003-2008 Associate Professor, Department of Surgery 2008-present Professor, Department of Surgery 2014-present Chief, Department of Transplantation & Vascular Surgery Ajou University Hospital Society Korean Society of Transplantation since Mar 1990 ASTS(American Society of Transplant Surgeons) since March 2000 The Transplantation Society since April 2004
Publications 1. Safety and Efficacy of the Early Introduction of Everolimus with Reduced-Exposure Cyclosporin A in De Novo Kidney Recipients. Transplantation 99: 180-186, 2015 2. Age-matching improves graft survival after living donor kidney transplantation. Transplant Proc 46(2): 449-453, 2014 3. New Predictive Marker for Hemodialysis Access Dysfunction. Semin Dial 27(1): 61-67, 2014 4. Angioplasty of communicating veins to the brachial vein in haemodialysis patients with obliterated superficial veins of the upper arm. Clin Radiol 69: 703-708, 2014 5. Clinical Significance of Prophylactic Antibiotics in Renal Transplantation. Transplant Proc 45(4): 1392-1395, 2013 6. Endovascular Treatment for Immature Autogenous Arteriovenous Fistula. Clin Radiol 68: e309-e315, 2013 7. A Venotomy and Manual Propulsion Technique to Treat Native Arteriovenous Fistulas Occluded by Thrombi. AJR 198: 460-465, 2012 8. Clinical Significance of Upper-arm Cephalic Vein Patency in Autogenous Radial-cephalic Wrist Fistulas for Hemodialysis. Eur J Vasc Endovasc Surg 44: 514-520, 2012 9. The impact of A(H1N1)pdm09 infection on renal transplant recipients: A multicenter cohort study. J Infect 65: 88-89, 2012 10. Prospective Controlled Protocol for 3 Months Steroid Withdrawal with Tacrolimus, Basiliximab, and Mycophenolate mofetil in Renal Transplant Recipients. J Korean Med Sci
27: 337-342, 2012 11. Kidney Transplantation from a Donor following Cardiac Death supported with Extracorporeal Membrane Oxygenation. J Korean Med Sci 27: 115-119, 2012 12. Cytokine gene expression in peripheral blood mononuclear cells during acute renal allograft rejection. Transplant Proc 44: 236-240, 2012 13. Impact of the Ratio of Graft Kidney Volume to Recipient Body Surface Area on Graft Function After Live Donor Kidney Transplantation. Clin Transplant 25: E647-E655, 2011 14. Predicting the Ideal Serum Creatinine of Kidney Transplant Recipients by a Simple Formula Based on the Balance Between Metabolic Demands of Recipients and Renal Mass Supply From Donors. Transplant Proc 40: 2307-2309, 2008 15. Beneficial Effects on the Renal Function of Both Recipients and Donors in Living Donor Kidney Transplantation. Transplant Proc 40: 2310-2312, 2008 16. Survival Analysis of Korean End-Stage Renal Disease Patients According to Renal Replacement Therapy in a Single Center. J Korean Med Sci 22: 81-88, 2007 17. Routine screening for the functional asymmetry of potential kidney donors. Transplant Proc 38: 1971-1973, 2006 18. Effect of Basiliximab on renal allograft rejection within 1 year after transplantation. Transplant Proc 38: 2025-2028, 2006 19. Fractional creatinine clearance of the donated kidney using Cockcroft-Gault formula as a predictor of graft function after living donor transplantation. Transplant Proc 38: 1974-1976, 2006 20. Gender-related differences of renal mass supply and metabolic demand after living donor
kidney transplantation. Clin Transplant 20: 163-170, 2006 21. Chronologically different impacts of immunologic and non-immunologic risk factors on renal allograft function. Clin Transplant 19: 742-750, 2005 22. Metabolic demand and renal mass supply affecting the early graft function after living donor kidney transplantation. Kidney Int 67: 744-749, 2005 23. Gene Expression of Perforin by Peripheral Blood Lymphocytes as a Marker of Acute Rejection. Nephron Clinical Practice 100: c63-c70, 2005 24. Independent Predictors for Primary Non-Function after Liver Transplantation. Yonsei Med J 45: 1155-1161, 2004 25. Influence of Donor and Recipient Gender on the Early Graft Function after Living Donor Kidney Transplantation. Transplant Proc 36: 2015-2017, 2004 26. Cloning and cell type-specific regulation of the human tyrosine hydroxylase gene promoter. Biochem Biophys Res Commun 312: 1123-1131, 2003 27. Portal Vein Reconstruction in Right Lobe Living-Donor Liver Transplantation. J Am Coll Surg 194: 96-98, 2001 28. Uni-and multi-variate analysis of risk factros for early and late hepatic artery thrombosis after liver transplantation. Transplantation 71: 767-772, 2001 29. Implication of advanced donor age on the outcome of liver transplantation. Clin Transplant 14: 386-390, 2000 30. Characteristic of infectious complication sassociated with mortality after solid organ transplantation. Clin Transplant 14: 401-408, 2000 31. Immunologic and nonimmunologic contributors to glomerular segmental sclerosis in renal transplantation. Transplant Proc 28: 1224-1225, 1996
32. Clinical validity of Banff grading of chronic rejection in renal transplantation. Transplant Proc 28: 1441-1442, 1996 33. A 16-year experience with 1275 primary living donor kidney transplants: univariate and multivariate analysis of risk factors affecting graft survival. Transplant Proc 28: 1578-1579, 1996 34. De novo cancer in transplant recipients. Transplant Proc 28: 1651-1652, 1996 35. Treatment of steroid resistant acute rejection after renal transplantation. Transplant Proc 28: 1453-1454, 1996 36. Causes of early or late patient death after living donor renal transplantation. Transplant Proc 26: 2019-2020, 1994 37. Causes of early and late renal allograft failure in the Cyclosporine era. Transplant Proc 26: 2021-2022, 1994 38. Single center experience of 1,000 primary living donor kidney transplants: Univariate and multivariate analysis of risk factors affecting graft survival. Transplant Proc 26: 2159-2160, 1994 39. Proteinuria after renal allograft: Assessment based on severity and causes. Transplant Proc 26: 2132-2133, 1994